275 related articles for article (PubMed ID: 12404085)
21. Interplay between glutamate and serotonin within the dorsal periaqueductal gray modulates anxiety-related behavior of rats exposed to the elevated plus-maze.
Moraes CL; Bertoglio LJ; Carobrez AP
Behav Brain Res; 2008 Dec; 194(2):181-6. PubMed ID: 18675851
[TBL] [Abstract][Full Text] [Related]
22. Anxiogenic-like effects of mCPP microinfusions into the amygdala (but not dorsal or ventral hippocampus) in mice exposed to elevated plus-maze.
Cornélio AM; Nunes-de-Souza RL
Behav Brain Res; 2007 Mar; 178(1):82-9. PubMed ID: 17207863
[TBL] [Abstract][Full Text] [Related]
23. GABA(A) receptor blockade in dorsomedial and ventromedial nuclei of the hypothalamus evokes panic-like elaborated defensive behaviour followed by innate fear-induced antinociception.
Freitas RL; Uribe-Mariño A; Castiblanco-Urbina MA; Elias-Filho DH; Coimbra NC
Brain Res; 2009 Dec; 1305():118-31. PubMed ID: 19799880
[TBL] [Abstract][Full Text] [Related]
24. m-Chlorophenylpiperazine (mCPP) modulates the discriminative stimulus effects of cocaine through actions at the 5-HT2C receptor.
Frankel PS; Cunningham KA
Behav Neurosci; 2004 Feb; 118(1):157-62. PubMed ID: 14979792
[TBL] [Abstract][Full Text] [Related]
25. 5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats.
Kimura Y; Naitou Y; Wanibuchi F; Yamaguchi T
Eur J Pharmacol; 2008 Jul; 589(1-3):157-62. PubMed ID: 18582863
[TBL] [Abstract][Full Text] [Related]
26. SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist.
Kennett GA; Wood MD; Bright F; Trail B; Riley G; Holland V; Avenell KY; Stean T; Upton N; Bromidge S; Forbes IT; Brown AM; Middlemiss DN; Blackburn TP
Neuropharmacology; 1997; 36(4-5):609-20. PubMed ID: 9225286
[TBL] [Abstract][Full Text] [Related]
27. Influence of serotonergic 5-HT2C receptor antagonist mesulergine in the reversal of memory deficits induced by mCPP.
Khaliq S; Haider S; Saleem S; Memon Z; Haleem DJ
J Coll Physicians Surg Pak; 2012 Feb; 22(2):75-9. PubMed ID: 22313641
[TBL] [Abstract][Full Text] [Related]
28. Brain angiotensin and anxiety-related behavior: the transgenic rat TGR(ASrAOGEN)680.
Voigt JP; Hörtnagl H; Rex A; van Hove L; Bader M; Fink H
Brain Res; 2005 Jun; 1046(1-2):145-56. PubMed ID: 15869747
[TBL] [Abstract][Full Text] [Related]
29. Involvement of median raphe nucleus 5-HT1A receptors in the regulation of generalized anxiety-related defensive behaviours in rats.
Vicente MA; Zangrossi H; dos Santos L; de Macedo CE; Andrade TG
Neurosci Lett; 2008 Nov; 445(3):204-8. PubMed ID: 18789373
[TBL] [Abstract][Full Text] [Related]
30. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.
Bagdy G; Graf M; Anheuer ZE; Modos EA; Kantor S
Int J Neuropsychopharmacol; 2001 Dec; 4(4):399-408. PubMed ID: 11806866
[TBL] [Abstract][Full Text] [Related]
31. Effect of the activation of central 5-HT2C receptors by the 5-HT2C agonist mCPP on blood pressure and heart rate in rats.
Ferreira HS; Oliveira E; Faustino TN; Silva Ede C; Fregoneze JB
Brain Res; 2005 Apr; 1040(1-2):64-72. PubMed ID: 15804427
[TBL] [Abstract][Full Text] [Related]
32. Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations.
Kõks S; Männistö PT; Bourin M; Shlik J; Vasar V; Vasar E
J Psychiatry Neurosci; 2000 Jan; 25(1):33-42. PubMed ID: 10721682
[TBL] [Abstract][Full Text] [Related]
33. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.
Wesołowska A; Nikiforuk A; Stachowicz K; Tatarczyńska E
Neuropharmacology; 2006 Sep; 51(3):578-86. PubMed ID: 16828124
[TBL] [Abstract][Full Text] [Related]
34. Selective serotonin receptor stimulation of the medial nucleus accumbens causes differential effects on food intake and locomotion.
Pratt WE; Blackstone K; Connolly ME; Skelly MJ
Behav Neurosci; 2009 Oct; 123(5):1046-57. PubMed ID: 19824770
[TBL] [Abstract][Full Text] [Related]
35. In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.
Kennett GA; Wood MD; Glen A; Grewal S; Forbes I; Gadre A; Blackburn TP
Br J Pharmacol; 1994 Mar; 111(3):797-802. PubMed ID: 7912626
[TBL] [Abstract][Full Text] [Related]
36. Role of 5-HT2C receptors of the dorsal hippocampus in the modulation of anxiety- and panic-related defensive responses in rats.
Sant'Ana AB; Vilela-Costa HH; Vicente MA; Hernandes PM; de Andrade TGCS; Zangrossi H
Neuropharmacology; 2019 Apr; 148():311-319. PubMed ID: 30685402
[TBL] [Abstract][Full Text] [Related]
37. 5-HT2c receptor activation induces grooming behaviour in rats: possible correlations with obsessive-compulsive disorder.
Gráf M
Neuropsychopharmacol Hung; 2006 Mar; 8(1):23-8. PubMed ID: 16841562
[TBL] [Abstract][Full Text] [Related]
38. Selective and nonselective serotonin antagonists block the aversive stimulus properties of MK212 and m-chlorophenylpiperazine (mCPP) in mice.
Walker EA; Kohut SJ; Hass RW; Brown EK; Prabandham A; Lefever T
Neuropharmacology; 2005 Dec; 49(8):1210-9. PubMed ID: 16165167
[TBL] [Abstract][Full Text] [Related]
39. Extinction-induced "despair" in the water maze, exploratory behavior and fear: effects of chronic antidepressant treatment.
Schulz D; Buddenberg T; Huston JP
Neurobiol Learn Mem; 2007 May; 87(4):624-34. PubMed ID: 17223365
[TBL] [Abstract][Full Text] [Related]
40. Partial 5-HT(1A) receptor agonist activity by the 5-HT(2C) receptor antagonist SB 206,553 is revealed in rats spinalized as neonates.
Shumsky JS; Kao T; Amato N; Simansky K; Murray M; Moxon KA
Exp Neurol; 2005 Feb; 191(2):361-5. PubMed ID: 15649492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
